• Study on the Safety and Effectiveness of BGB-11417 Alone and with Dexamethasone, Carfilzomib, Daratumumab, or Pomalidomide for Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    1 1 1 1
    France Germany Greece Italy Spain
  • Study Comparing Meropenem and Piperacillin/Tazobactam for Adults with Sepsis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark Sweden
  • Continued Access Study for Patients with Severe Hemophilia A Using Efanesoctocog Alfa

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Germany Greece Italy The Netherlands +4
  • Study on the Effectiveness and Safety of Clindamycin and Tretinoin Gel for Patients with Papulopustular Acne

    Recruiting

    3 1 1
    Investigated Drugs:
    Germany
  • Study Comparing Ustekinumab, Infliximab, and Combination Therapy for Patients with Moderate to Severe Ulcerative Colitis

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Study on 68Ga-FAPI-46 for Predicting Treatment Response in Early-Stage High-Risk Triple-Negative Breast Cancer Patients Undergoing Chemo-Immunotherapy

    Recruiting

    1 1 1 1
    Investigated Diseases:
    France
  • Study Comparing Rivaroxaban and Drug Combination for Preventing Blood Clots in Patients with Lower Limb Injuries Requiring Immobilization

    Recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study Comparing Chemotherapy with Irinotecan, Folinic Acid, and Oxaliplatin for Patients with Locally Recurrent Rectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium The Netherlands Norway Portugal Sweden
  • Study of Metolazone and Acetazolamide Combination for Patients with Acute Heart Failure and Volume Overload

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Study on CART45RA-NKG2D Cells for Children, Adolescents, and Young Adults with Advanced Sarcoma

    Recruiting

    1 1 1
    Investigated Drugs:
    Spain

powered by